Susan Ringdal, Vice-President at Hikma Pharmaceuticals, holds 119.82K shares in Hikma Pharmaceuticals (Ticker: GB:HIK). Most recently, Susan Ringdal Sold 38,222 shares of Hikma Pharmaceuticals on Jun 02, 2026 for an estimated value of 553.84K .
What is the percentage of profitable transactions made by Susan Ringdal?
The percentage of profitable transactions made by Susan Ringdal is 67%.
What is the average return per transaction made by Susan Ringdal?
The average return per transaction made by Susan Ringdal is 9.70%.
What stocks does Susan Ringdal hold?
Susan Ringdal holds: GB:HIK stocks.
What was Susan Ringdal’s latest transaction?
Susan Ringdal latest transaction was an Informative Sell of 553.84K .
What was Susan Ringdal's most profitable transaction?
Susan Ringdal’s most profitable transaction was an Informative Sell of GB:HIK stock on March 4, 2025. The return on the trade was 40.10%.
What is Susan Ringdal's role in Hikma Pharmaceuticals?
Susan Ringdal's role in Hikma Pharmaceuticals is Vice-President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.